HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cu-ATSM, an intracellular-accessible superoxide dismutase (SOD)-like copper complex: evaluation in an ischemia-reperfusion injury model.

Abstract
We have reported a stable superoxide dismutase (SOD)-like copper complex, Cu-ATSM, which shows high membrane permeability and distribution to the brain or heart. In this study, we evaluated the protective effects of Cu-ATSM on superoxide-mediated tissue damage caused by ischemia-reperfusion using an isolated perfused rat heart model. Lipid peroxidation levels in the Cu-ATSM treated group were lower than those in the non-treated group. Furthermore, released creatine phosphokinase into the perfusate, a marker of tissue damage, was reduced by Cu-ATSM treatment. These results indicated the possibility of Cu-ATSM being an effective SOD-like drug for the treatment of superoxide-mediated damage, such as ischemia-reperfusion injury.
AuthorsK Wada, Y Fujibayashi, N Tajima, A Yokoyama
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 17 Issue 5 Pg. 701-4 (May 1994) ISSN: 0918-6158 [Print] Japan
PMID7920437 (Publication Type: Journal Article)
Chemical References
  • Coordination Complexes
  • Free Radical Scavengers
  • Organometallic Compounds
  • Thiobarbituric Acid Reactive Substances
  • Thiosemicarbazones
  • copper (II) diacetyl-di(N(4)-methylthiosemicarbazone)
  • Superoxides
  • Superoxide Dismutase
  • Creatine Kinase
Topics
  • Animals
  • Coordination Complexes
  • Coronary Circulation (drug effects)
  • Creatine Kinase (metabolism)
  • Free Radical Scavengers
  • Hemodynamics (drug effects)
  • In Vitro Techniques
  • Male
  • Myocardial Ischemia (drug therapy, physiopathology)
  • Myocardial Reperfusion Injury (drug therapy, physiopathology)
  • Myocardium (enzymology)
  • Organometallic Compounds (pharmacology)
  • Rats
  • Rats, Wistar
  • Superoxide Dismutase (pharmacology)
  • Superoxides (toxicity)
  • Thiobarbituric Acid Reactive Substances (metabolism)
  • Thiosemicarbazones (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: